Vimarsana
Biggest News Aggregation in the World

Page 12 - Stroke Statistics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stroke Statistics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stroke Statistics Today - Breaking & Trending Today

The Effect of Lifestyle Modifications on Risk for Valvular Heart Disease - Vimarsana News

The Effect of Lifestyle Modifications on Risk for Valvular Heart Disease

Dr Neel Chokshi, Dr Katarzyna Gil, Dr Justin Bachmann, and Dr Mariell Jessup discuss lifestyle modifications for valvular heart disease.

Low Cholesterol Diet For Beginners: Foods To Lower Cholesterol - Vimarsana News

Low Cholesterol Diet For Beginners: Foods To Lower Cholesterol

A low-cholesterol diet protects your heart and can reduce disease risk. Read to learn how to lower cholesterol from your diet and body 2023.

Understanding the Impact of COVID-19 on Cardiovascular Disease - Vimarsana News

Understanding the Impact of COVID-19 on Cardiovascular Disease

(Family Features) Now, more than three years from the onset of the COVID-19 pandemic, the impacts can be seen more clearly.

Forxiga approved in China to reduce the risk of cardiovascular death and hospitalisation in adult patients with symptomatic chronic heart failure - Vimarsana News

Forxiga approved in China to reduce the risk of cardiovascular death and hospitalisation in adult patients with symptomatic chronic heart failure

Forxiga approved in China to reduce the risk of cardiovascular death and hospitalisation in adult patients with symptomatic chronic heart failureThe first and only heart failure therapy with a proven mortality benefit now approved for patients with heart failure regardless of ejection fraction status Forxiga&nb...

Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress - Vimarsana News

Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress

DUBLIN, Ireland and BRIDGEWATER, N.J., July 26, 2023 -- Amarin Corporation plc today announced the acceptance of funded research for presentation at the European Society of Cardiology Congress,...